CAUTION: We have been advised that fraudulent emails with a modified domain name have been sent by a source purporting to be from Aird & Berlis LLP. These communications are not legitimate and are not from Aird & Berlis LLP. Disregard any such emails and do not engage with the sender or the email in any way. Please report the attempted fraud by contacting the Canadian Anti-Fraud Centre and by emailing Aird & Berlis LLP at

Back to all blog posts

Posted in: Intellectual Property | Trademarks

Apr 29, 2020

Federal Court Grants Interlocutory Injunction Restraining Cease and Desist Letters

Fluid Energy Group Ltd. (“Fluid”) and Exaltexx Inc. (“Exaltexx”) are direct competitors in the sale of chemicals to the oil and gas industry. After commencing an action asserting infringement of nine patents by Exaltexx, Fluid sent cease and desist letters to companies that sold raw materials and provided transportation services to Exaltexx. The letters, at least in part, had the desired result. The transportation company declined to provide further services to Exaltexx. Based on a statutory requirement that prohibits making false and misleading statements about a competitor, a Federal Court judge granted an interlocutory injunction restraining further distribution of such letters. The decision can be seen here.

Exaltexx’s injunction motion was based on section 7(a) of the Trademarks Act, which prohibits a person from making false or misleading statements tending to discredit the business, goods or services of a competitor. While only found in the Trademarks Act, this section equally applies to patent and copyright matters.

For an injunction to be granted, the moving party must satisfy a three-part test: a serious issue to be tried; irreparable harm if the relief is not granted; and that the balance of convenience favours the moving party.

In assessing whether a serious issue was presented, the Court found that Fluid’s cease and desist letters were “threatening” (as opposed to “informative”). The letters demanded that the recipients cease supplying raw materials and providing transportation services to Exaltexx. A copy of the statement of claim was also enclosed, presumably to foreshadow what would occur if the recipient did not comply.

Upon receipt of the cease and desist letter, the trucking company, a small business, wrote to Exaltexx and indicated that it had no choice but to stop handling its products.

Exaltexx’s evidence established that the supplier only provided hydrochloric acid. None of the asserted patents claimed hydrochloric acid or the use of hydrochloric acid by itself. Since the sale of hydrochloric acid by itself could not infringe, there was a serious issue as to whether the allegations of infringement in the cease and desist letter were false and misleading. Similarly, the trucking company did not buy or sell the impugned product, only stored and shipped it. This, too, raised a serious issue that the allegations of patent infringement in the cease and desist letter were false and misleading.

The grant of an interlocutory injunction in patent cases is rare. Most motions fail on the second part of the test: irreparable harm – harm that cannot be adequately compensated by payment of damages. Here, the Court found that there was clear and non-speculative evidence of irreparable harm, namely damage to Exaltexx’s business reputation; harm to relationships with suppliers; the potential impact on Exaltexx’s business as a whole given the size of the industry and the size of Exaltexx; and the difficulties associated with quantifying the nature of that harm.

The balance of convenience also favoured Exaltexx. The grant of the injunction would not in any way curtail Fluid’s ability to promote its products. Nor would it prevent Fluid from appropriately enforcing its patent rights, either through litigation or through bona fide pre-litigation communications.

The injunction did not entirely prevent fluid from sending cease and desist letters. The evidence on the motion did not establish that the allegations of infringement relating to products made, used or sold by Exaltexx were false and misleading.

This decision was grounded solely on section 7(a) of the Trademarks Act. The Patent Act was recently amended (section 76.2) to provide a cause of action for written demands made in respect of a patented invention that do not “comply with the prescribed requirements.” Regulations setting out these requirements have yet to be promulgated. When they are, patent owners will be obliged to exercise further discretion before delivering a cease and desist letter.

Areas of Expertise

Related Categories

Related Blogs

Posted in: Trademarks | Court Decision | Intellectual Property

Insights TheSpotlight
The Supreme Court of Canada’s Clarifies Standard of Review for Trademark Appeals By Lawrence Veregin and Ken Clark Feb 28, 2020 The Supreme Court of Canada’s recent decision in Canada (Minister of Citizenship and Immigration) v. Vavilov, 2019 SCC 65 revised the test for determining the standard of review for courts reviewing decisions from administrative bodies.

Posted in: Intellectual Property | Trademarks | TheSpotlight Categories

Insights TheSpotlight
Aird & Berlis Trademark Practice and Practitioners Recognized in WTR 1000 By Timothy M. Lowman, R. Grant Cansfield and Ken Clark Feb 14, 2020 Aird & Berlis is proud to be recognized in the 2020 edition of World Trademark Review 1000: The World’s Leading Trademark Professionals at both the firm and individual levels.

Posted in: Trademarks

Insights TheSpotlight
Changes to Canada’s Trademarks Act By Ken Clark, R. Grant Cansfield and Timothy M. Lowman Jun 04, 2019 It has been a long time coming, but effective June 17, 2019, Canada’s new Trademarks Act takes force. Trademark applications filed after June 17 will be evaluated using Canada’s new rules.

Posted in: Trademarks

Insights TheSpotlight
Cannabis Trademarks Remain Unregistrable in U.S. Despite Federal Circuit’s Ruling in Re: Brunetti By Ken Clark Jan 31, 2018 In a decision released on December 15, 2017, the Court of Appeals for the Federal Circuit struck down the Lanham Act’s ban on registering “immoral” or “scandalous” trademarks as an unconstitutional violation of free speech. Re Brunetti removes a significant b...